Published in Nat Cell Biol on May 01, 1999
The specificities of protein kinase inhibitors: an update. Biochem J (2003) 7.76
Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A (2008) 3.71
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci U S A (2005) 2.00
Genome-scale promoter engineering by coselection MAGE. Nat Methods (2012) 1.69
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS. Front Mol Neurosci (2011) 1.47
Enterohemorrhagic Escherichia coli biofilms are inhibited by 7-hydroxyindole and stimulated by isatin. Appl Environ Microbiol (2007) 1.36
Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog (2007) 1.29
Role of STAT3 in cancer metastasis and translational advances. Biomed Res Int (2013) 1.29
Chemical modulation of memory formation in larval zebrafish. Proc Natl Acad Sci U S A (2011) 1.27
Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells. Br J Cancer (2001) 1.24
Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity. Antimicrob Agents Chemother (2004) 1.21
GSK-3β: A Bifunctional Role in Cell Death Pathways. Int J Cell Biol (2012) 1.21
Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ Health Perspect (2009) 1.18
Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants. Arch Biochem Biophys (2007) 1.06
Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid. BMC Cancer (2010) 1.05
Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells. J Virol (2007) 1.04
Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. J Cancer Res Clin Oncol (2004) 1.02
Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments. Cancer Res (2011) 1.02
6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells. Cancer Res (2011) 1.02
Culturable endophytes of medicinal plants and the genetic basis for their bioactivity. Microb Ecol (2012) 1.01
Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period. J Med Chem (2008) 1.01
Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors. Cancers (Basel) (2015) 0.99
Marine compounds selectively induce apoptosis in female reproductive cancer cells but not in primary-derived human reproductive granulosa cells. Mar Drugs (2012) 0.97
Malassezia yeasts produce a collection of exceptionally potent activators of the Ah (dioxin) receptor detected in diseased human skin. J Invest Dermatol (2013) 0.96
Biosynthesis of the active compounds of Isatis indigotica based on transcriptome sequencing and metabolites profiling. BMC Genomics (2013) 0.95
Mutations of toluene-4-monooxygenase that alter regiospecificity of indole oxidation and lead to production of novel indigoid pigments. Appl Environ Microbiol (2005) 0.95
Investigation of the biosynthetic potential of endophytes in traditional Chinese anticancer herbs. PLoS One (2012) 0.95
Mechanism targeted discovery of antitumor marine natural products. Curr Med Chem (2004) 0.95
Discovery of new anticancer agents from higher plants. Front Biosci (Schol Ed) (2012) 0.92
Characterization of a novel phenol hydroxylase in indoles biotransformation from a strain Arthrobacter sp. W1 [corrected]. PLoS One (2012) 0.92
Bioactivity of the Murex Homeopathic Remedy and of Extracts from an Australian Muricid Mollusc against Human Cancer Cells. Evid Based Complement Alternat Med (2010) 0.91
Multiple phosphorylation events control mitotic degradation of the muscle transcription factor Myf5. BMC Biochem (2005) 0.91
p21(Waf1/Cip1) deficiency stimulates centriole overduplication. Cell Cycle (2006) 0.90
Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells. Mol Oncol (2012) 0.90
Tau as a therapeutic target for Alzheimer's disease. Curr Alzheimer Res (2011) 0.89
Modulating polo-like kinase 1 as a means for cancer chemoprevention. Pharm Res (2010) 0.87
Purified brominated indole derivatives from Dicathais orbita induce apoptosis and cell cycle arrest in colorectal cancer cell lines. Mar Drugs (2013) 0.87
Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling. Mol Oncol (2012) 0.86
The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting. Hum Gene Ther (2012) 0.86
12/15-lipoxygenase contributes to platelet-derived growth factor-induced activation of signal transducer and activator of transcription 3. J Biol Chem (2013) 0.85
Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model. Blood (2010) 0.85
Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors. J Mol Model (2009) 0.85
Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor. Nucleic Acids Res (2015) 0.84
An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3. Parasit Vectors (2014) 0.83
Antimicrobial, antimycobacterial and antibiofilm properties of Couroupita guianensis Aubl. fruit extract. BMC Complement Altern Med (2012) 0.83
Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime. AIDS Res Hum Retroviruses (2011) 0.83
Iodine/palladium approaches to the synthesis of polyheterocyclic compounds. J Org Chem (2010) 0.82
Biological targets for isatin and its analogues: Implications for therapy. Biologics (2007) 0.82
Cytochrome P450 1A, 1B, and 1C mRNA induction patterns in three-spined stickleback exposed to a transient and a persistent inducer. Comp Biochem Physiol C Toxicol Pharmacol (2011) 0.82
Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3'-oxime from molecular dynamics simulations. J Mol Model (2006) 0.81
Recent progress in neuroactive marine natural products. Nat Prod Rep (2014) 0.81
Synthesis of a dual functional anti-MDR tumor agent PH II-7 with elucidations of anti-tumor effects and mechanisms. PLoS One (2012) 0.80
Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases. Evid Based Complement Alternat Med (2015) 0.80
Development of an HTS-compatible assay for the discovery of ASK1 signalosome inhibitors using alphascreen technology. Assay Drug Dev Technol (2014) 0.80
A novel role of the aryl hydrocarbon receptor (AhR) in centrosome amplification - implications for chemoprevention. Mol Cancer (2010) 0.80
Are the Traditional Medical Uses of Muricidae Molluscs Substantiated by Their Pharmacological Properties and Bioactive Compounds? Mar Drugs (2015) 0.79
Cell migration in paediatric glioma; characterisation and potential therapeutic targeting. Br J Cancer (2015) 0.79
Biotechnological applications of functional metagenomics in the food and pharmaceutical industries. Front Microbiol (2015) 0.79
Indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) is a potent modulator of LPS-stimulated macrophage functions. Toxicol Appl Pharmacol (2012) 0.79
Indirubin 3'-monoxime, from a Chinese traditional herbal formula, suppresses viremia in humanized mice infected with multidrug-resistant HIV. AIDS Res Hum Retroviruses (2014) 0.79
Recombinant Leishmania mexicana CRK3:CYCA has protein kinase activity in the absence of phosphorylation on the T-loop residue Thr178. Mol Biochem Parasitol (2010) 0.79
Recent advances in the search for antiviral agents against human papillomaviruses. Antivir Ther (2007) 0.79
RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification. Oncotarget (2015) 0.78
MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells. Cancer Biol Ther (2013) 0.77
The small molecule indirubin-3'-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity. Int J Obes (Lond) (2013) 0.77
Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases. ACS Med Chem Lett (2012) 0.77
Structural basis for the modulation of CDK-dependent/independent activity of cyclin D1. Cell Cycle (2006) 0.77
In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells. Gene Ther (2015) 0.77
Characterization of anti-leukemia components from Indigo naturalis using comprehensive two-dimensional K562/cell membrane chromatography and in silico target identification. Sci Rep (2016) 0.76
Potential of protein kinase inhibitors for treating herpesvirus-associated disease. Trends Microbiol (2013) 0.76
Anti-inflammatory effects of indirubin derivatives on influenza A virus-infected human pulmonary microvascular endothelial cells. Sci Rep (2016) 0.76
Structure-based design of potent CDK1 inhibitors derived from olomoucine. J Comput Aided Mol Des (2000) 0.76
In vitro and in vivo protective effects of proteoglycan isolated from mycelia of Ganoderma lucidum on carbon tetrachloride-induced liver injury. World J Gastroenterol (2006) 0.76
A computational study of the protein-ligand interactions in CDK2 inhibitors: using quantum mechanics/molecular mechanics interaction energy as a predictor of the biological activity. Biophys J (2006) 0.76
An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin. PLoS One (2013) 0.76
Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3'-oxime (7BIO). Cancer Cell Int (2015) 0.75
Inhibitory effects of Persicariae Rhizoma aqueous extracts on experimental periodontitis and alveolar bone loss in Sprague-Dawley rats. Exp Ther Med (2016) 0.75
Schiff bases of indoline-2,3-dione (isatin) with potential antiproliferative activity. Chem Cent J (2012) 0.75
Biotransformation of Indigo Pigment by Indigenously Isolated Pseudomonas sp. HAV-1 and Assessment of Its Antioxidant Property. Biotechnol Res Int (2014) 0.75
Indirubin Increases CD4+CD25+Foxp3+ Regulatory T Cells to Prevent Immune Thrombocytopenia in Mice. PLoS One (2015) 0.75
6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells. Mol Ther (2017) 0.75
Cancer and virus leads by HTS, chemical design and SEA data mining. Curr Top Med Chem (2009) 0.75
Analysis of the extracts of Isatis tinctoria by new analytical approaches of HPLC, MS and NMR. Afr J Tradit Complement Altern Med (2011) 0.75
Genotoxicity testing of Persicariae Rhizoma (Persicaria tinctoria H. Gross) aqueous extracts. Exp Ther Med (2016) 0.75
Rapid Identification and Verification of Indirubin-Containing Medicinal Plants. Evid Based Complement Alternat Med (2015) 0.75
Isatin derivatives with activity against apoptosis-resistant cancer cells. Bioorg Med Chem Lett (2016) 0.75
Molecular dynamics study of the inhibitory effects of ChEMBL474807 on the enzymes GSK-3β and CDK-2. J Mol Model (2015) 0.75
The role of natural indigo dye in alleviation of genotoxicity of sodium dithionite as a reducing agent. Cytotechnology (2016) 0.75
Screening of cell cycle fusion proteins to identify kinase signaling networks. Cell Cycle (2015) 0.75
Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells. Immune Netw (2017) 0.75
Inhibition mechanism of CDK-2 and GSK-3β by a sulfamoylphenyl derivative of indoline-a molecular dynamics study. J Mol Model (2017) 0.75
Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice. PLoS One (2017) 0.75
Cloning and characterization of indole synthase (INS) and a putative tryptophan synthase α-subunit (TSA) genes from Polygonum tinctorium. Plant Cell Rep (2016) 0.75
Indirubin Inhibits LPS-Induced Inflammation via TLR4 Abrogation Mediated by the NF-kB and MAPK Signaling Pathways. Inflammation (2016) 0.75
New hydrazonoindolin-2-ones: Synthesis, exploration of the possible anti-proliferative mechanism of action and encapsulation into PLGA microspheres. PLoS One (2017) 0.75
Enumeration and Cell Cycle Analysis of Natural Populations of Marine Picoplankton by Flow Cytometry Using the Nucleic Acid Stain SYBR Green I. Appl Environ Microbiol (1997) 5.16
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood (1997) 4.78
cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF. Cell (1988) 4.12
The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat Cell Biol (1999) 3.83
Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature (1987) 3.79
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood (1997) 3.56
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science (1998) 3.53
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature (1999) 3.50
Growth of prochlorococcus, a photosynthetic prokaryote, in the equatorial pacific ocean. Science (1995) 2.92
Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem (1994) 2.82
Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation (1999) 2.80
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J Biol Chem (2001) 2.79
Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem (1997) 2.65
Sublingual capnometry: a new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med (1999) 2.54
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst (1999) 2.41
The crystal structure of cyclin A. Structure (1995) 2.28
Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J Biol Chem (2000) 2.27
A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. Cell Death Differ (2010) 2.25
Electron beam computed tomographic coronary calcium as a predictor of coronary events: comparison of two protocols. Circulation (1997) 2.24
Gastric intramural PCO2 during peritonitis and shock. Chest (1993) 2.13
Fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes to identify small phytoplankton by flow cytometry. Appl Environ Microbiol (1995) 2.06
Flow cytometric detection of viruses. J Virol Methods (2000) 2.05
COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J (2001) 1.97
Racial differences in the significance of coronary calcium in asymptomatic black and white subjects with coronary risk factors. J Am Coll Cardiol (1999) 1.97
Airway protection during experimental CPR. Chest (1995) 1.96
Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25. Eur J Biochem (2000) 1.93
Odontogenic tumours: a retrospective study of 1642 cases in a Chinese population. Int J Oral Maxillofac Surg (2006) 1.91
Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in vivo formation of N-nitroso compounds. Food Cosmet Toxicol (1976) 1.88
Activation of M-phase-specific histone H1 kinase by modification of the phosphorylation of its p34cdc2 and cyclin components. Genes Dev (1990) 1.86
Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res (1995) 1.77
Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. Chem Biol (2000) 1.75
Effect of Phosphorus on the Synechococcus Cell Cycle in Surface Mediterranean Waters during Summer. Appl Environ Microbiol (1996) 1.74
Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. J Clin Invest (1997) 1.74
Optimizing timing of ventricular defibrillation. Crit Care Med (2001) 1.74
cDNA cloning of murine Nrf 2 gene, coding for a p45 NF-E2 related transcription factor. Biochem Biophys Res Commun (1995) 1.73
Genetic analysis by peptide nucleic acid affinity MALDI-TOF mass spectrometry. Nat Biotechnol (1997) 1.71
Cytologic grading of invasive breast carcinoma. Correlation with clinicopathologic variables and predictive value of nodal metastasis. Acta Cytol (2000) 1.68
Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors? Am J Cardiol (1996) 1.67
Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest (1996) 1.66
Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies. J Thromb Haemost (2012) 1.66
Comparisons between sublingual and gastric tonometry during hemorrhagic shock. Chest (2000) 1.62
ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre. Eur Respir J (2011) 1.61
Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. J Biol Chem (1999) 1.56
p53-null cells are more sensitive to ultraviolet light only in the presence of caffeine. Cancer Res (1996) 1.54
ATP-site directed inhibitors of cyclin-dependent kinases. Curr Med Chem (1999) 1.52
Diacylglycerol kinase epsilon regulates seizure susceptibility and long-term potentiation through arachidonoyl- inositol lipid signaling. Proc Natl Acad Sci U S A (2001) 1.51
Inactivation of p53 results in high rates of homologous recombination. Oncogene (1997) 1.51
Networking senescence-regulating pathways by using Arabidopsis enhancer trap lines. Plant Physiol (2001) 1.49
Mandibular coronoid fractures: treatment options. Int J Oral Maxillofac Surg (2013) 1.48
Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity. J Med Chem (1999) 1.47
The structure of CDK4/cyclin D3 has implications for models of CDK activation. Proc Natl Acad Sci U S A (2009) 1.45
A novel endonuclease mechanism directly visualized for I-PpoI. Nat Struct Biol (1999) 1.43
Heterochromatin study demonstrating the non-linearity of fluorometry useful for calculating genomic base composition. Cytometry (1993) 1.43
Prognostic significance of cardiac cinefluoroscopy for coronary calcific deposits in asymptomatic high risk subjects. J Am Coll Cardiol (1994) 1.42
Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. Cancer Res (1999) 1.41
Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors. J Virol (2001) 1.40
Lung carcinoma induction in BD rats after a single intratracheal instillation of an arsenic-containing pesticide mixture formerly used in vineyards. Int J Cancer (1979) 1.40
CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. Oncogene (2008) 1.39
Concussions during the 1997 Canadian Football League season. Clin J Sport Med (2000) 1.37
Pfnek-1, a NIMA-related kinase from the human malaria parasite Plasmodium falciparum Biochemical properties and possible involvement in MAPK regulation. Eur J Biochem (2001) 1.37
High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation (1997) 1.36
Risk factors and medical follow-up of drug users tested for hepatitis C--can the risk of transmission be reduced? Drug Alcohol Rev (1997) 1.35
Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr (2001) 1.35
Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine. Proteins (1995) 1.35
Offline assessment of atherosclerotic coronary calcium from electron beam tomograms. Am J Card Imaging (1995) 1.34
The cyclin box fold: protein recognition in cell-cycle and transcription control. Trends Biochem Sci (1997) 1.34
Sequential dephosphorylation of p34(cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition. J Biol Chem (1996) 1.33
The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Exp Cell Res (1998) 1.32
Molecular cloning and characterization of a novel human diacylglycerol kinase zeta. J Biol Chem (1996) 1.31
Exofacial epitope-tagged glucose transporter chimeras reveal COOH-terminal sequences governing cellular localization. J Cell Biol (1993) 1.30
Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension. Plant J (1997) 1.28
Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem (1997) 1.28
Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation (1997) 1.26
Activation of myelin basic protein kinases during echinoderm oocyte maturation and egg fertilization. Dev Biol (1988) 1.26
Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors. Chem Biol (1999) 1.26
Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells. Br J Cancer (2001) 1.24
Human rsk isoforms: cloning and characterization of tissue-specific expression. Am J Physiol (1994) 1.23
Thermococcus barophilus sp. nov., a new barophilic and hyperthermophilic archaeon isolated under high hydrostatic pressure from a deep-sea hydrothermal vent. Int J Syst Bacteriol (1999) 1.22
Acupuncture mycobacteriosis. N Engl J Med (2001) 1.20
Genome size and base composition in Medicago sativa and M. truncatula species. Genome (1994) 1.20
Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene (2000) 1.18
Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitions. FEBS Lett (1994) 1.18
Uncorrected refractive error in Singapore teenagers. Br J Ophthalmol (2006) 1.17
A class of distribution-free models for longitudinal mediation analysis. Psychometrika (2013) 1.17
A novel interaction between HER2/neu and cyclin E in breast cancer. Oncogene (2010) 1.17
5-Hydroxymethylfurfural: assessment of mutagenicity, DNA-damaging potential and reactivity towards cellular glutathione. Food Chem Toxicol (2000) 1.17
Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Nat Struct Biol (1997) 1.16